Resveratrol, a naturally occurring plant compound, inhibited STAT5 activation in CML cell lines, providing a potential CML treatment (Li et al., 2018). This evidence concerns the gene STAT5A and chronic myelogenous leukemia, BCR-ABL1 positive.